Search Results - Rick L Haas
- Showing 1 - 6 results of 6
-
1
-
2
PropAngio study protocol: a neoadjuvant trial on the efficacy of propranolol monotherapy in cutaneous angiosarcoma—a proof of principle study by Neeltje Steeghs, Jos H Beijnen, Kimberley M Heinhuis, Nikki S IJzerman, Anne Miek Koenen, Winette T A van der Graaf, Rick L Haas, Alwin D R Huitema, Winan J van Houdt
Published in BMJ Open (2020-09-01)Get full text
Article -
3
Long-term survival of participants in the PASART-1 and PASART-2 trials of neo-adjuvant pazopanib and radiotherapy in soft tissue sarcoma by Bauke H.G. van Riet, Milan van Meekeren, Marta Fiocco, Aisha Miah, Ilse de Pree, Lisette M. Wiltink, Astrid Scholten, Lotte Heimans, Judith V.M.G. Bovée, Hans Gelderblom, Neeltje Steeghs, Rick L. Haas
Published in Acta Oncologica (2025-01-01)Get full text
Article -
4
Evaluating the effectiveness of a risk prediction model (PERSARC) on improving treatment decisions quality for patients with soft-tissue sarcomas: the VALUE-PERSARC study by Anouk A. Kruiswijk, Perla J. Marang-van de Mheen, Lisa A. E. Vlug, Ellen G. Engelhardt, Marta Fiocco, Rick L. Haas, Yvonne M. Schrage, Cornelis Verhoef, Marc H. A. Bemelmans, Robert J. van Ginkel, Johannes J. Bonenkamp, Arjen J. Witkamp, Michiel A. J. van de Sande, Leti van Bodegom-Vos, VALUE-PERSARC research group
Published in BMC Medical Informatics and Decision Making (2025-09-01)Get full text
Article -
5
(Cost-)effectiveness of an individualised risk prediction tool (PERSARC) on patient’s knowledge and decisional conflict among soft-tissue sarcomas patients: protocol for a parallel... by Cornelis Verhoef, Rick L Haas, Elske M van den Akker-van Marle, Leti van Bodegom-Vos, Michiel A J van de Sande, Ellen G Engelhardt, Perla Marang-van de Mheen, Anouk A Kruiswijk, Yvonne M Schrage, Robert J van Ginkel, Han Bonenkamp, Marc HA Bemelmans, Ibtissam Acem, Stefanie Hakkesteegt, Roos F Bleckman, Marloes van Duijvenbode, Nicolette Leijerzapf, Jos A van der Hage, Robert J.P. van der Wal
Published in BMJ Open (2023-11-01)Get full text
Article -
6
Divergent therapeutic and prognostic impacts of immunogenic features in undifferentiated pleomorphic sarcoma and myxofibrosarcoma by Siddh van Oost, Debora M. Meijer, Zeynep B. Erdem, Marieke E. IJsselsteijn, Jessica Roelands, Suk Wai Lam, Melissa S. Boejharat, Brendy E. W. M. van den Akker, Ruud van der Breggen, Inge H. Briare-de Bruijn, Lukas J. A. C. Hawinkels, Anouk A. Kruiswijk, Manon van der Ploeg, Pauline M. Wijers-Koster, Rick L. Haas, Michiel A. J. van den Sande, Noel F. C. C. de Miranda, Judith V. M. G. Bovee
Published in Cancer Immunology, Immunotherapy (2025-07-01)Get full text
Article
